HC Q study #101
See all studies
Early treatment study
Sulaiman et al., medRxiv, doi:10.1101/2020.09.09.20184143 (Preprint)
The Effect of Early Hydroxych loroquine-based Therapy in COVID-19 Patients in Ambulatory Care Settings: A Nationwide Prospective Cohort Study
Observational prospective 5,541 patients, adjusted HC Q mortality odds ratio OR 0.36, p = 0.012. Adjusted hospitalization OR 0.57, p < 0.001. Zinc supplementation was used in all cases. Early treatment in ambulatory fever clinics in Saudi Arabia.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.